Cerity Partners LLC Seagen Inc. Transaction History

Cerity Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$191.51 - $216.16 $49,984 - $56,417	-261 Reduced 13.21%	1,715 $363,000
Q2 2023 Aug 14, 2023	SELL	$187.64 - $206.25 $33,587 - $36,918	-179 Reduced 8.31%	1,976 $380,000
Q1 2023 May 11, 2023	BUY	$127.59 - $203.08 $62,391 - $99,306	489 Added 29.35%	2,155 $436,000
Q4 2022 Feb 15, 2023	BUY	$117.37 - $139.17 $195,538 - $231,857	1,666 New	1,666 $214,000
Q3 2021 Oct 25, 2021	SELL	$142.45 - $169.82 $1.43 Million - $1.7 Million	-10,005 Closed	0 $0

Q2 2021 Aug 11, 2021	SELL	$135.08 - $161.1 $5,133 - $6,121	-38 Reduced 0.38%	10,005 $1.58 Million
Q1 2021 Aug 11, 2021	BUY	$137.51 - $190.8 $1.38 Million - $1.92 Million	10,043 New	10,043 $1.4 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Cerity Partners LLC with notifications on news.